![]() |
市場調查報告書
商品編碼
1446223
全球醫藥級卡波姆市場2024-2028Global Pharmaceutical Grade Carbomers Market 2024-2028 |
預計2023-2028年醫藥級卡波姆市場將成長1.1307億美元,預測期內複合年成長率為6.39%。
該報告包括對醫藥級卡波姆市場的總體分析、市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。
它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括對局部給藥系統的需求迅速成長、全球老年人口的增加以及個人護理和化妝品中擴大加入藥用級卡波姆。
市場範圍 | |
---|---|
基準年 | 2024年 |
結束年份 | 2028年 |
預測期 | 2024-2028 |
成長動力 | 加速度 |
2024年與前一年同期比較 | 5.48% |
複合年成長率 | 6.39% |
增量 | 11307萬美元 |
該研究指出,對永續和環境友善製造方法的日益關注是推動未來幾年醫藥級卡波姆市場成長的關鍵原因之一。此外,對使用醫藥級卡波姆的生物黏附藥物傳輸系統的需求不斷成長以及水凝膠的日益採用也將帶來巨大的市場需求。
The pharmaceutical grade carbomers market is forecasted to grow by USD 113.07 mn during 2023-2028, accelerating at a CAGR of 6.39% during the forecast period. The report on the pharmaceutical grade carbomers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surge in demand for topical drug delivery systems, increasing global geriatric population, and increasing incorporation of pharmaceutical grade carbomers in personal care and cosmetic products.
Technavio's pharmaceutical grade carbomers market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 5.48% |
CAGR | 6.39% |
Incremental Value | $113.07mn |
By Application
By Type
By Geographical Landscape
This study identifies the increasing focus on sustainable and eco-friendly manufacturing practices as one of the prime reasons driving the pharmaceutical grade carbomers market growth during the next few years. Also, rising need for bioadhesive drug delivery systems using pharmaceutical grade carbomers and growing adoption of hydrogels will lead to sizable demand in the market.
The report on the pharmaceutical grade carbomers market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical grade carbomers market vendors that include 3V Sigma SpA, Anhui Newman Fine Chemicals Co. Ltd., Arihant Innochem Pvt. Ltd., Ashahi Chemical Industries Pvt. Ltd., Ashland Inc., Azelis SA, Berkshire Hathaway Inc., Corel Pharma Chem, East India Chemicals International, Evonik Industries AG, Golden Falcon General Trading LLC, Guangzhou Tinci Advanced Materials Co. Ltd., HENAN JINHE INDUSTRY CO. LTD., IMCD NV, JENE CHEMICALS, Libraw Pharma Excipients Pvt. Ltd., Maruti Chemicals, Merck KGaA, Muby Chemicals, Pioma Chemicals, Shreeji Pharma International, Sumitomo Seika Chemicals Co. Ltd., The SNF Group, Unilong Industry Co. Ltd, and Vizag Chemical International. Also, the pharmaceutical grade carbomers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: